KentuckySB 772026 Regular SessionSenate

AN ACT relating to ibogaine research in the Commonwealth.

Sponsored By: Donald Douglas (Republican)

Became Law

AgricultureAppropriationsBudget And Financial AdministrationDrugs And MedicinesEffective Dates, EmergencyFundsOpioidsPublic HealthState Agencies

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Bill Overview

Analyzed Economic Effects

2 provisions identified: 1 benefits, 0 costs, 1 mixed.

Kentucky creates an ibogaine research fund

The law creates a state fund, run by Kentucky’s Department of Agriculture, to support public-private ibogaine drug trials. It can receive state, federal, and private money, but the law sets no funding amount. Uncommitted money is invested under state rules; investment earnings and unspent balances carry forward each year. Receipts from selling or licensing intellectual property created through the partnership must go into the fund. Spending is limited to programs or research helping at-risk people with conditions treatable with ibogaine. These include opioid and related substance use disorders, post-traumatic stress disorder, traumatic brain injury, and other neurological or mental health disorders.

Kentucky trial funding comes with requirements

Drug developers can partner with Kentucky for ibogaine trials aimed at Food and Drug Administration approval. Before contracting, they must document an existing agreement with another state or state-sponsored group. They must provide trial designs, team qualifications, financial disclosures, and plans to seek federal Breakthrough Therapy status. Required trial plans cover recruitment, screening, drug administration, after-care, and follow-up treatment support. Developers must match Kentucky’s investment dollar-for-dollar; both amounts fund Kentucky trials using in-state clinicians, facilities, and participants. Contracts require a post-approval plan that prioritizes Kentucky residents, seeks insurer coverage, and creates access paths for low-income and uninsured people. The plan also covers training and credentials for Kentucky medical providers. Kentucky receives a share of intellectual-property proceeds based on its contribution to total multistate trial costs. Contracts require periodic deposits into the fund during funding and commercialization. Developers submit quarterly trial progress and financial reports verifying state spending and matching funds. The department reports to lawmakers by December 1 each year until trials conclude. It can accept reasonable contract changes only when Kentucky keeps substantially equal value.

Sponsors & Cosponsors

Sponsor

  • Donald Douglas

    Republican • Senate

Cosponsors

  • Aaron Reed

    Republican • Senate

  • Danny Carroll

    Republican • Senate

  • Lindsey Tichenor

    Republican • Senate

  • Shelley Funke Frommeyer

    Republican • Senate

  • Scott Madon

    Republican • Senate

  • Steve Rawlings

    Republican • Senate

Roll Call Votes

All Roll Calls

Yes: 225 • No: 34

Senate vote • 4/14/2026

passed

Yes: 31 • No: 6

House vote • 4/14/2026

passed

Yes: 77 • No: 18

House vote • 4/1/2026

3rd reading, passed

Yes: 82 • No: 8

Senate vote • 3/13/2026

3rd reading, passed

Yes: 35 • No: 2

Actions Timeline

  1. delivered to Secretary of State (Acts Ch. 158)

    4/14/2026
  2. enrolled, signed by Speaker of the House

    4/14/2026Senate
  3. enrolled, signed by President of the Senate

    4/14/2026Senate
  4. received in Senate

    4/14/2026Senate
  5. passed 77-18

    4/14/2026House
  6. veto overridden

    4/14/2026House
  7. posted for consideration of Governor's veto

    4/14/2026
  8. taken from Rules (H)

    4/14/2026House
  9. to Rules (H)

    4/14/2026House
  10. received in House

    4/14/2026House
  11. passed 31-6

    4/14/2026Senate
  12. veto overridden

    4/14/2026Senate
  13. posted for passage for consideration of Governor's veto

    4/14/2026
  14. to Rules (S)

    4/14/2026Senate
  15. received in Senate

    4/14/2026Senate
  16. Vetoed

    4/13/2026
  17. delivered to Governor

    4/1/2026
  18. enrolled, signed by Speaker of the House

    4/1/2026Senate
  19. enrolled, signed by President of the Senate

    4/1/2026Senate
  20. received in Senate

    4/1/2026Senate
  21. 3rd reading, passed 82-8

    4/1/2026House
  22. placed in the Orders of the Day

    4/1/2026House
  23. taken from Rules

    4/1/2026House
  24. 2nd reading, to Rules

    3/25/2026House
  25. reported favorably, 1st reading, to Calendar

    3/24/2026House

Bill Text

  • Current

    4/14/2026

  • Introduced

    1/8/2026

Related Bills

Back to State Legislation